Seeing Is Believing

Currently out of the existing stock ratings of Thomas Allen, 52 are a HOLD (26.94%), 116 are a BUY (60.1%), 25 are a SELL (12.95%).
Analyst Thomas Allen, currently employed at MORGAN STANLEY, carries an average stock price target met ratio of 85.21% that have a potential upside of 28.01% achieved within 492 days.
Thomas Allen’s has documented 452 price targets and ratings displayed on 24 stocks. The coverage is on Consumer Cyclical, Healthcare sectors.
Most recent stock forecast was given on TMDX, TransMedics Group at 07-Nov-2023.
Analyst best performing recommendations are on TMDX (TRANSMEDICS GROUP).
The best stock recommendation documented was for DKNG (DRAFTKINGS) at 3/9/2021. The price target of $66 was fulfilled within 1 day with a profit of $3.8 (6.11%) receiving and performance score of 61.09.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 11-Jul-2025
$89
$2.8 (3.25%)
$90
11 days ago
(11-Feb-2026)
13/15 (86.67%)
$5.59 (6.70%)
239
Hold Since 05-Jan-2024
$95
$8.8 (10.21%)
$90
16 days ago
(06-Feb-2026)
18/21 (85.71%)
$11.76 (14.13%)
344
Hold Since 24-Feb-2025
$87
$0.8 (0.93%)
$85
1 months 6 days ago
(16-Jan-2026)
24/24 (100%)
$-1.65 (-1.86%)
141
Buy Since 17-Jan-2023
$99
$12.8 (14.85%)
$89
3 months 29 days ago
(24-Oct-2025)
10/11 (90.91%)
$20.4 (25.95%)
424
Hold Since 23-Jun-2025
$89
$2.8 (3.25%)
$79
4 months 6 days ago
(16-Oct-2025)
16/19 (84.21%)
$7.07 (8.63%)
520
What Year was the first public recommendation made by Thomas Allen?